Share：
Share this content in WeChat
X
[Chinese][PDF]6972
• Clinical Article •
Prediction of axillary lymph node metastasis in breast cancer based on intra-tumoral and peri-tumoral MRI radiomics nomogram
ZHAO Nannan  ZHU Yun  TANG Xiaomin  YANG Zhao  LI Yang  ZHANG Shuni  WANG Lingling  LI Xiaoguang  XIE Zongyu 

Cite this article as: ZHAO N N, ZHU Y, TANG X M, et al. Prediction of axillary lymph node metastasis in breast cancer based on intra-tumoral and peri-tumoral MRI radiomics nomogram[J]. Chin J Magn Reson Imaging, 2023, 14(3): 81-87, 94. DOI:10.12015/issn.1674-8034.2023.03.014.


[Abstract] Objective To investigate the value of dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) based intra-tumoural and peri-tumoural radiomics nomogram in predicting axillary lymph node (ALN) metastases in breast cancer patients.Materials and Methods A total of 180 breast cancer patients with confirmed by preoperative DCE-MRI and pathology in the First Affiliated Hospital of Bengbu Medical College were retrospectively analyzed, which was randomly divided into a training set (n=126) and a test set (n=54) in a ratio of 7∶3. Firstly, the region of interest (ROI) was outlined at the largest level of the DCE-MRI stage 2 lesion with a conformal outreach of 6 mm, and the optimal ROI was selected by regression with the least absolute shrinkage and selection operator (LASSO). The intra-tumoural, peri-tumoural and intra+peri-tumoural radiomics scores (Rad-score) were obtained by support vector machine (SVM) to construct the intra-tumour, peri-tumour and intra+peri-tumour models respectively. The clinical model was constructed by screening clinical risk factors through single-multifactor logistic regressionby, and the most effective intra+peri-tumoural Rad-score combined with the clinical risk factors was selected to construct the radiomics nomogram. The predictive performance of each model was analyzed using the receiver operating characteristic (ROC) curve and the correspongding area under the curve (AUC) was calculated. The clinical practicability of the prediction models was assessed using calibration curves.Results The nomogram model has the best diagnostic performance. And the AUC, sensitivity, specificity, and accuracy of the nomogram model was 0.945, 87.5%, 93.0%, 92.6% for the training set and 0.942, 90.9%, 90.6%, 90.2% for the test set respectively.Conclusions The nomogram model is essential in the preoperative prediction of ALN metastasis in breast cancer, which can precisely and non-invasively provide important guidance for clinical decision-making in a scientific and non-invasive manner.
[Keywords] breast cancer；lymph nodes；axillary node；peri-tumor；magnetic resonance imaging；radiomics；nomogram

ZHAO Nannan1, 2   ZHU Yun1   TANG Xiaomin1   YANG Zhao1, 2   LI Yang1, 2   ZHANG Shuni1, 2   WANG Lingling3   LI Xiaoguang4   XIE Zongyu1*  

1 Department of Radiology, the First Affiliated Hospital of Bengbu Medical College, Bengbu 233004, China

2 Graduate School of Bengbu Medical College, Bengbu 233004, China

3 School of Medical Imaging, Bengbu Medical College, Bengbu 233004, China

4 Department of Radiology, Daping Hospital, Army Medical University, Chongqing 400042, China

Corresponding author: Xie ZY, E-mail: zongyuxie@sina.com

Conflicts of interest   None.

ACKNOWLEDGMENTS Key Project of Natural Science Fund of Anhui Provincial Department of Education (No. KJ2019A0402); University-Level Project of Bengbu Medical College (No. 2022byzd012).
Received  2022-11-09
Accepted  2023-02-28
DOI: 10.12015/issn.1674-8034.2023.03.014
Cite this article as: ZHAO N N, ZHU Y, TANG X M, et al. Prediction of axillary lymph node metastasis in breast cancer based on intra-tumoral and peri-tumoral MRI radiomics nomogram[J]. Chin J Magn Reson Imaging, 2023, 14(3): 81-87, 94. DOI:10.12015/issn.1674-8034.2023.03.014.

[1]
SIEGEL R L, MILLER K D, JEMAL A. Cancer statistics, 2015[J]. CA A Cancer J Clin, 2015, 65(1): 5-29. DOI: 10.3322/caac.21254.
[2]
HUMPHREY K L, SAKSENA M A, FREER P E, et al. To do or not to do: axillary nodal evaluation after ACOSOG Z0011 Trial[J]. Radiographics, 2014, 34(7): 1807-1816. DOI: 10.1148/rg.347130141.
[3]
ANDERSSON Y, BERGKVIST L, FRISELL J, et al. Long-term breast cancer survival in relation to the metastatic tumor burden in axillary lymph nodes[J]. Breast Cancer Res Treat, 2018, 171(2): 359-369. DOI: 10.1007/s10549-018-4820-0.
[4]
LEITHNER D, MOY L, MORRIS E A, et al. Abbreviated MRI of the breast: does it provide value?[J/OL]. J Magn Reson Imaging, 2019, 49(7): e85-e100 [2022-09-12]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6408315. DOI: 10.1002/jmri.26291.
[5]
LEITHNER D, WENGERT G J, HELBICH T H, et al. Clinical role of breast MRI now and going forward[J]. Clin Radiol, 2018, 73(8): 700-714. DOI: 10.1016/j.crad.2017.10.021.
[6]
KUHL C K, SCHRADING S, BIELING H B, et al. MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study[J]. Lancet, 2007, 370(9586): 485-492. DOI: 10.1016/S0140-6736(07)61232-X.
[7]
PINKER K, HELBICH T H, MORRIS E A. The potential of multiparametric MRI of the breast[J/OL]. Br J Radiol, 2017, 90(1069): 20160715 [2022-09-12]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5605035. DOI: 10.1259/bjr.20160715.
[8]
MITTAL S, BROWN N J, HOLEN I. The breast tumor microenvironment: role in cancer development, progression and response to therapy[J]. Expert Rev Mol Diagn, 2018, 18(3): 227-243. DOI: 10.1080/14737159.2018.1439382.
[9]
LAMBIN P, RIOS-VELAZQUEZ E, LEIJENAAR R, et al. Radiomics: extracting more information from medical images using advanced feature analysis[J]. Eur J Cancer, 2012, 48(4): 441-446. DOI: 10.1016/j.ejca.2011.11.036.
[10]
D'ORSI C J, SICKLES E A, MENDELSON E B, et al. ACR BI-RADS® Atlas, Breast Imaging Reporting and Data System[M]. Reston: American College of Radiology, 2013.
[11]
HYUN S J, KIM E K, YOON J H, et al. Adding MRI to ultrasound and ultrasound-guided fine-needle aspiration reduces the false-negative rate of axillary lymph node metastasis diagnosis in breast cancer patients[J]. Clin Radiol, 2015, 70(7): 716-722. DOI: 10.1016/j.crad.2015.03.004.
[12]
CHATTERJI M, MERCADO C L, MOY L. Optimizing 1.5-Tesla and 3-Tesla dynamic contrast-enhanced magnetic resonance imaging of the breasts[J]. Magn Reson Imaging Clin N Am, 2010, 18(2): 207-224. DOI: 10.1016/j.mric.2010.02.011.
[13]
ZHANG S H, WANG X L, YANG Z, et al. Intra- and peritumoral radiomics model based on early DCE-MRI for preoperative prediction of molecular subtypes in invasive ductal breast carcinoma: a multitask machine learning study[J/OL]. Front Oncol, 2022, 12: 905551 [2022-09-15]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263840. DOI: 10.3389/fonc.2022.905551.
[14]
CHANG J M, LEUNG J W T, MOY L, et al. Axillary nodal evaluation in breast cancer: state of the art[J]. Radiology, 2020, 295(3): 500-515. DOI: 10.1148/radiol.2020192534.
[15]
ARNETH B. Tumor microenvironment[J/OL]. Medicina (Kaunas), 2019, 56(1): 15 [2022-10-03]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7023392. DOI: 10.3390/medicina56010015.
[16]
LIU Y, LI X, ZHU L N, et al. Preoperative prediction of axillary lymph node metastasis in breast cancer based on intratumoral and peritumoral DCE-MRI radiomics nomogram[J/OL]. Contrast Media Mol Imaging, 2022, 2022: 6729473 [2022-10-03]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9410821. DOI: 10.1155/2022/6729473.
[17]
MING J, CHEN Y, LIU Y, et al. Value of preoperative prediction of Ki-67 expression in breast cancer based on DCE-MRI intratumoral combined with peritumoral radiomics model[J]. Chin J Magn Reson Imaging, 2022, 13(10): 132-137, 149. DOI: 10.12015/issn.1674-8034.2022.10.020.
[18]
BEIG N, KHORRAMI M, ALILOU M, et al. Perinodular and intranodular radiomic features on lung CT images distinguish adenocarcinomas from granulomas[J]. Radiology, 2019, 290(3): 783-792. DOI: 10.1148/radiol.2018180910.
[19]
DONG Y H, FENG Q J, YANG W, et al. Preoperative prediction of sentinel lymph node metastasis in breast cancer based on radiomics of T2-weighted fat-suppression and diffusion-weighted MRI[J]. Eur Radiol, 2018, 28(2): 582-591. DOI: 10.1007/s00330-017-5005-7.
[20]
CONTI A, DUGGENTO A, INDOVINA I, et al. Radiomics in breast cancer classification and prediction[J]. Semin Cancer Biol, 2021, 72: 238-250. DOI: 10.1016/j.semcancer.2020.04.002.
[21]
YU H W, MENG X Q, CHEN H, et al. Correlation between mammographic radiomics features and the level of tumor-infiltrating lymphocytes in patients with triple-negative breast cancer[J/OL]. Front Oncol, 2020, 10: 412 [2022-10-03]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7174560. DOI: 10.3389/fonc.2020.00412.
[22]
CHENG Y, XU S, WANG H T, et al. Intra- and peri-tumoral radiomics for predicting the sentinel lymph node metastasis in breast cancer based on preoperative mammography and MRI[J/OL]. Front Oncol, 2022, 12: 1047572 [2023-01-30]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792138. DOI: 10.3389/fonc.2022.1047572.
[23]
BRAMAN N, PRASANNA P, WHITNEY J, et al. Association of peritumoral radiomics with tumor biology and pathologic response to preoperative targeted therapy for HER2 (ERBB2)–positive breast cancer[J/OL]. JAMA Netw Open, 2019, 2(4): e192561 [2023-01-30]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481453. DOI: 10.1001/jamanetworkopen.2019.2561.
[24]
BRAMAN N M, ETESAMI M, PRASANNA P, et al. Intratumoral and peritumoral radiomics for the pretreatment prediction of pathological complete response to neoadjuvant chemotherapy based on breast DCE-MRI[J/OL]. Breast Cancer Res, 2017, 19(1): 57 [2022-10-05]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5437672. DOI: 10.1186/s13058-017-0846-1.
[25]
MAO N, SHI Y H, LIAN C, et al. Intratumoral and peritumoral radiomics for preoperative prediction of neoadjuvant chemotherapy effect in breast cancer based on contrast-enhanced spectral mammography[J]. Eur Radiol, 2022, 32(5): 3207-3219. DOI: 10.1007/s00330-021-08414-7.
[26]
WANG S M, SUN Y Q, LI R M, et al. Diagnostic performance of perilesional radiomics analysis of contrast-enhanced mammography for the differentiation of benign and malignant breast lesions[J]. Eur Radiol, 2022, 32(1): 639-649. DOI: 10.1007/s00330-021-08134-y.
[27]
YANG J F, DING X F, ZHU W D. Improving the calling of non-invasive prenatal testing on 13-/ 18-/ 21-trisomy by support vector machine discrimination[J/OL]. PLoS One, 2018, 13(12): e0207840 [2023-01-31]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6281214. DOI: 10.1371/journal.pone.0207840.
[28]
ZHANG S H, WANG X L, ZHU Y, et al. The value of intra-tumoral and peri-tumoral early dynamic contrast-enhanced MRI-based radiomics models in identifying benign from malignant in breast imaging-reporting and data system 4 breast tumors[J]. Chin J Radiol, 2022, 56(7): 758-765. DOI: 10.3760/cma.j.cn112149-20210829-00616.
[29]
LIN F, WANG Z Y, ZHANG K, et al. Contrast-enhanced spectral mammography-based radiomics nomogram for identifying benign and malignant breast lesions of sub-1 cm[J/OL]. Front Oncol, 2020, 10: 573630 [2022-10-12]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7662120. DOI: 10.3389/fonc.2020.573630.
[30]
HU D X, ZHOU J, HE W, et al. Risk factors of lateral lymph node metastasis in cN0 papillary thyroid carcinoma[J/OL]. World J Surg Oncol, 2018, 16(1): 30 [2022-10-13]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5811970. DOI: 10.1186/s12957-018-1336-3.
[31]
CHEN S, HARMON S, PERK T, et al. Using neighborhood gray tone difference matrix texture features on dual time point PET/CT images to differentiate malignant from benign FDG-avid solitary pulmonary nodules[J/OL]. Cancer Imaging, 2019, 19(1): 56 [2022-10-15]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6697997. DOI: 10.1186/s40644-019-0243-3.
[32]
PÉREZ-MORALES J, TUNALI I, STRINGFIELD O, et al. Peritumoral and intratumoral radiomic features predict survival outcomes among patients diagnosed in lung cancer screening[J/OL]. Sci Rep, 2020, 10(1): 10528 [2022-10-15]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7324394. DOI: 10.1038/s41598-020-67378-8.
[33]
ALBERT K, GAU V, TAYLOR W D, et al. Attention bias in older women with remitted depression is associated with enhanced amygdala activity and functional connectivity[J]. J Affect Disord, 2017, 210: 49-56. DOI: 10.1016/j.jad.2016.12.010.
[34]
ZHU Y Q, JI H, ZHU Y F, et al. Predictive value of preoperative MRI-based nomogram for axillary lymph node metastasis in breast cancer[J]. Chin J Magn Reson Imaging, 2022, 13(5): 52-58. DOI: 10.12015/issn.1674-8034.2022.05.010.
[35]
ZHANG D L, QIAN Y F, LI W, et al. Analysis of factors affecting axillary lymph node metastasis of breast cancer and comparative study of different diagnostic methods[J]. J China Clin Med Imaging, 2021, 32(2): 94-99. DOI: 10.12117/jccmi.2021.02.005.
[36]
ZHU Y, ZHANG S H, WANG X L, et al. Value of a nomogram based on MRI, mammography and pathology for predicting sentinel lymph node metastasis of mass-type breast invasive ductal carcinoma[J]. Chin J Magn Reson Imaging, 2022, 13(5): 45-51. DOI: 10.12015/issn.1674-8034.2022.05.009.
[37]
FUSCO R, SANSONE M, GRANATA V, et al. Use of quantitative morphological and functional features for assessment of axillary lymph node in breast dynamic contrast-enhanced magnetic resonance imaging[J/OL]. Biomed Res Int, 2018, 2018: 2610801 [2022-10-20]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5998166. DOI: 10.1155/2018/2610801.
[38]
ZONG Q, DENG J, GE W, et al. Establishment of simple nomograms for predicting axillary lymph node involvement in early breast cancer[J]. Cancer Manag Res, 2020, 12: 2025-2035. DOI: 10.2147/cmar.s241641.

PREV Study on the correlation between multi-parameter MRI and pathology in the tumor body and peritumoral area of breast cancer
NEXT Value of cardiac magnetic resonance feature tracking in the evaluation of ventricular function in uncomplicated obesity subjects
  


LINK


Tel & Fax: +8610-67113815    E-mail: editor@cjmri.cn